ArticleGland surgery2026
Metabolic syndrome is an independent correlate of breast nodules: a retrospective case-control study.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast nodules are a common clinical finding in women, and their association with metabolic syndrome (MetS) remains unclear. This study aimed to investigate the independent relevant factors for breast nodules, with a focus on MetS. Methods: We analyzed health examination data from 667 women in 2024, with 300 participants (150 with breast nodules and 150 without) randomly selected for analysis. Data included medical history, metabolic parameters, psychological evaluations, and breast ultrasound reports [breast imaging reporting and data system, Breast Imaging Reporting and Data System (BI-RADS) classification]. Results: The prevalence of breast nodules was 65.97% (440/667). Women with breast nodules exhibited a significantly higher average height (160.89±5.65 Conclusions: Multivariate regression analysis identified MetS [odds ratio (OR) =3.453; 95% confidence interval (CI): 1.569-7.601] and height (OR =1.060 per 1 cm increase, 95% CI: 1.018-1.103) as independent relevant factors. These findings suggest that metabolic health interventions may play an important role in breast nodules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.